ArticleJournal of gastrointestinal oncology2025
Targeting metabolism in pancreatic ductal adenocarcinoma: challenges and insights from the AVENGER 500 trial.
Elizabeth S Nakasone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.